Regulations.gov document
Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing Cross-Contamination…
Other · FDA-2011-D-0104 · posted Jun 24, 2022
Key facts
| Document ID | FDA-2011-D-0104-0019 |
|---|---|
| Title | Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing Cross-Contamination; Guidance for Industry; DRAFT GUIDANCE |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2011-D-0104 |
| Posted | Jun 24, 2022 |
| Comment period opens | Jun 24, 2022 |
| Comments due | Aug 24, 2022 |
At a glance
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: